Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid & Recombinant), End User (Pharma, Biotech, CRO) - Global Forecast to 2026
The global peptide synthesis market in terms of revenue was estimated to be worth $515 million in 2021 and is poised to reach $730 million by 2026, growing at a CAGR of 7.2% from 2021 to 2026. Growth in this market is driven by the increasing use of peptides in pharmaceutical drugs, an increase in research activities and the availability of funding for R&D, and the development of advanced automated peptide synthesizers. However, the lack of a unified set of regulations for therapeutic peptides and the high cost of instruments are expected to restrain the growth of this market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
Peptide Synthesis Market Dynamics
Driver: Increasing use of peptides in pharmaceutical drugs
Peptides are highly active and highly specific drug substances. Due to the diversity of their biological functions, they are used in an extensive range of therapeutic areas. Peptides are increasingly entering drug development pathways as potential active pharmaceutical ingredients due to their large chemical space, high biological activity, high specificity, relative ease of synthesis, ready availability, and low toxicity. Oncology, diabetes, and obesity are three prominent therapeutic areas where peptides generate billions of dollars in revenues. The demand for peptides is also increasing for the treatment of cardiovascular and neurodegenerative diseases, renal failure, and rare diseases. Currently, there are more than 100 FDA-approved peptide-based drugs on the market. This number is expected to grow significantly, with approximately 700 peptide drugs and therapeutic peptides currently in clinical trials or preclinical development.
Restraint: Lack of a unified set of regulations for therapeutic peptides
Peptide-based drugs fall in the range of small-molecule and large-molecule biologics. Being at the borderline between typical small molecules and large proteins, peptides have raised a series of regulatory challenges. Most of these drugs are chemically synthesized. Though the synthesis process for different peptide drugs is similar, their action mechanisms vary widely. Hence, developing a unified set of regulatory guidelines that can effectively address the safety and quality requirements for such a diverse group of molecular entities with various unique mechanisms of action is a challenging task. There are no formal guidelines from any regulatory agency for developing this class of therapeutics. Also, there is a conflict between the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the regulatory approval of peptide-based drugs. As per the FDA, peptide drugs are classified as small-molecule drugs and fall under the FDA's Center for Drug Evaluation and Research (CDER) jurisdiction, whereas the EMA prefers a centralised procedure over the mutual recognition procedure (the marketing of peptide-based drugs is allowed throughout the European Union under the centralised procedure). This lack of a unified set of regulations has made it challenging to secure approvals for therapeutic peptides, which in turn is limiting their application areas. This is considered a major factor restraining the growth of the global peptide synthesis market.
Opportunity: Development of personalised medicines
Interest in personalised treatment has been fueled by the concept of tailored therapy with the best response and highest safety margin to ensure better patient care. Proteomic analysis is an appealing and powerful tool for characterising the molecular profiles of various tissues, both normal and diseased. Personalized proteomics, or proteomic profiling, is the next big step in personalised medicine; it provides clarity on disease pathomechanisms. To boost the use of proteomics in personalised medicine, scientists proposed the development of a user-friendly platform to programme electrochemically directed peptide synthesis based on a microfluidic multiplexing system controlled by software under the ElectroMed project funded by the European Union. The ligand-receptor complexes will then be detected and quantified by label-free sensors based on nanomaterials. The system will enable an automated injection of the different reagents needed for the ligand synthesis for the personalised and controlled synthesis of peptides, making possible the use of proteomics for personalised medicine. Growing investments in personalised medicine can primarily be attributed to the growing demand for advanced treatments with minimal side effects and the rising prevalence of diseases such as cancer and CVD. Personalized medicine holds promise for improving healthcare while also lowering costs. Such developments in the personalised medicine field will offer growth opportunities for players in the peptide synthesis market.
Challenge: Issues associated with the route of administration of peptide drugs
The majority of therapeutic peptides are administered via the parenteral route because of insufficient absorption from the gastrointestinal tract. Peptide drugs are usually indicated for chronic conditions, and the use of injections on a daily basis during long-term treatment has significant drawbacks. In contrast to this inconvenient and potentially problematic method of drug administration, the oral route offers advantages such as self-administration with a high degree of patient acceptability and compliance. The main reasons for the low oral bioavailability of peptide drugs are pre-systemic enzymatic degradation and poor penetration of the intestinal mucosa. Also, these therapeutics tend to have a high molecular weight, low lipophilicity, and charged functional groups that hamper their absorption. These characteristics lead to the low bioavailability and short half-lives of most orally administered peptides. Intravenous or subcutaneous delivery of these therapeutics overcomes the issue of absorption, but other factors limit the bioavailability of peptide and protein therapeutics, including systemic proteases, rapid metabolism, opsonization, conformational changes, dissociation of subunit proteins, non-covalent complexation with blood products, and destruction of labile side-groups.
In 2020, the reagents segment dominated the peptide synthesis market.
Based on product and service, the market is segmented into reagents, equipment, and services. In 2020, the reagents segment accounted for the largest share of the global market. The large share of this segment can be attributed to the growing applications of peptides in therapeutics, drug design, and gene synthesis; the frequent purchase of reagents in comparison to equipment; the rising number of ongoing research projects involving peptide synthesis; and the availability of various peptide synthesis reagents in the market.
To know about the assumptions considered for the study, download the pdf brochure
In 2020, North America was the largest regional market for Peptide Synthesis.
The peptide synthesis market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest share of the global market at 37.6%, followed by Europe and the Asia Pacific with shares of 29.8% and 26%, respectively. The increasing life science R&D, the high prevalence of chronic diseases, increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, and an increasing focus on developing personalised therapeutics all contribute to North America's large share of the global market. The US held the largest share of the North American market in 2020. The large share of the US is primarily attributed to the increasing life science research activities in the US and the growing prevalence of cancer and chronic diseases.
Key players in the peptide synthesis market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).
Peptide Synthesis Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$515 million |
|
Estimated Value by 2026 |
$730 million |
|
Growth Rate |
Poised to grow at a 7.2% |
|
Forecast units |
Value (USD) |
|
Segments covered |
Product & Service, Technology, End user and Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA) |
|
Companies covered |
Bachem Holding AG (Switzerland), Thermo Fisher Scientific (US), Merck KGaA (Germany), GenScript Biotech Corporation (China), Among others. |
This report categorizes the peptide synthesis market into the following segments and subsegments:
By Product & Service
- Reagents
- Equipment
- Services
By Reagents
- Resins
- Amino acids
- Coupling Reagents
- Dyes and Fluorescent labeling reagents
- Other Reagents
By Equipment
- Peptide Synthesizers
- Chromatography Equipment
- Lyophiizers
By Technology
- Solid-Phase Peptide Synthesis
- Solution-Phase Peptide Synthesis
- Hybrid & Recombinant Technology
By End user
- Pharmaceutical & Biotechnology companies
- CDMOs & CROs
- Academic & Research Institutes
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
-
Asia Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific (RoAPAC)
-
Latin America (LATAM)
- Brazil
- Mexico
- RoLATAM
- Middle East and Africa (MEA)
Recent Developments
- In August 2021, Bachem Holding AG (Switzerland) and Novo Nordisk (Denmark) collaborated to develop a greener technology for solid-phase peptide synthesis (SPPS), under which two studies were conducted to find solvent alternatives to replace the reprotoxic N,N-dimethylformamide (DMF), dichloromethane (DCM), and N-methyl-2-pyrrolidone (NMP).
- In February 2021, Thermo Fisher Scientific (US) introduced novel capillary chromatography columns for proteomics, clinical peptides, and biopharmaceutical research laboratories performing high throughput, high-performance liquid chromatography (HPLC), or liquid chromatography-mass spectrometry (LC-MS) analysis.
Frequently Asked Questions (FAQ):
What is the projected market value of the global peptide synthesis?
The global market of peptide synthesis is projected to reach USD 730 million by 2026.
What is the estimated growth rate (CAGR) of the global peptide synthesis market for the next five years?
The global peptide synthesis market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.2% from 2021 to 2026.
Who are the major players offering peptide synthesis in the market?
Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 34)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 38)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: PEPTIDE SYNTHESIS MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 GLOBAL MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2020
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 GLOBAL MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 GLOBAL MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 9 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD MILLION)
FIGURE 10 GLOBAL MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
FIGURE 11 GLOBAL MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET
4 PREMIUM INSIGHTS (Page No. - 51)
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
FIGURE 13 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND INCREASING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2020)
FIGURE 14 REAGENTS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2020
4.3 GLOBAL MARKET SHARE, BY TECHNOLOGY (2020)
FIGURE 15 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.5 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 17 ASIA PACIFIC COUNTRIES TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET FROM 2021 TO 2026
5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 1 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing use of peptides in pharmaceutical drugs
TABLE 2 PEPTIDE-BASED DRUGS APPROVED BY THE FOOD AND DRUG ADMINISTRATION (FDA) (2015–2019)
TABLE 3 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19
5.2.1.2 Increase in research activities and the availability of funding for R&D
FIGURE 19 INCREASE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.3 Development of advanced automated peptide synthesizers
5.2.2 RESTRAINTS
5.2.2.1 Lack of a unified set of regulations for therapeutic peptides
5.2.2.2 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets in the Asia Pacific region
5.2.3.2 Development of personalized medicines
5.2.4 CHALLENGES
5.2.4.1 Issues associated with the route of administration of peptide drugs
5.2.4.2 Addressing the environmental impact of chemical synthesis of peptides
5.3 RANGES/SCENARIOS
FIGURE 20 SPECTRUM OF SCENARIOS BASED ON THE IMPACT OF UNCERTAINTIES ON THE GROWTH OF THE PEPTIDE SYNTHESIS MARKET
5.4 IMPACT OF THE COVID-19 OUTBREAK ON THE PEPTIDE SYNTHESIS MARKET
FIGURE 21 PEPTIDE SYNTHESIS SCENARIO PRE AND POST COVID-19
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.6 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS OF THE PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.7 TECHNOLOGICAL ANALYSIS
TABLE 4 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES
5.8 PATENT ANALYSIS
FIGURE 23 PATENT APPLICATIONS FOR THE GLOBAL MARKET, JANUARY 2011–DECEMBER 2021
TABLE 5 INDICATIVE LIST OF PATENTS IN THE GLOBAL MARKET
5.9 ECOSYSTEM ANALYSIS OF THE GLOBAL MARKET
TABLE 6 SUPPLY CHAIN ECOSYSTEM
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF SUPPLIERS
5.10.4 BARGAINING POWER OF BUYERS
5.10.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS
5.11 REGULATORY ANALYSIS
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE (Page No. - 75)
6.1 INTRODUCTION
TABLE 8 GLOBAL MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
6.2 REAGENTS
TABLE 9 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 10 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 11 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 12 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 13 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 14 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.1 RESINS
6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost the market for resins
TABLE 15 PEPTIDE SYNTHESIS RESINS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 16 NORTH AMERICA: PEPTIDE SYNTHESIS RESINS MARKE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 17 EUROPE: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 18 ASIA PACIFIC: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 19 LATIN AMERICA: PEPTIDE SYNTHESIS RESINS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.2 AMINO ACIDS
6.2.2.1 Amino acids are the basic building blocks for peptide synthesis
TABLE 20 PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 21 NORTH AMERICA: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 22 EUROPE: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 23 ASIA PACIFIC: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 24 LATIN AMERICA: PEPTIDE SYNTHESIS AMINO ACIDS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.3 COUPLING REAGENTS
6.2.3.1 Coupling reagents play a vital role in the peptide bond formation
TABLE 25 PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 26 NORTH AMERICA: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 27 EUROPE: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 29 LATIN AMERICA: PEPTIDE SYNTHESIS COUPLING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.4 DYES & FLUORESCENT LABELING REAGENTS
6.2.4.1 Fluorescent labeling reagents are crucial to understand the success rate of peptide synthesis reactions
TABLE 30 PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 31 NORTH AMERICA: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 32 EUROPE: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 33 ASIA PACIFIC: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 34 LATIN AMERICA: PEPTIDE SYNTHESIS DYES & FLUORESCENT LABELING REAGENTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.2.5 OTHER REAGENTS
TABLE 35 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2019–2026 (USD MILLION)
TABLE 36 NORTH AMERICA: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 37 EUROPE: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 38 ASIA PACIFIC: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 39 LATIN AMERICA: MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019–2026 (USD MILLION)
6.3 EQUIPMENT
TABLE 40 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 41 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 43 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 44 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 45 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.1 PEPTIDE SYNTHESIZERS
6.3.1.1 Rising automation in peptide synthesizers to drive market growth
TABLE 46 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN THE MARKET
TABLE 47 PEPTIDE SYNTHESIZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 48 NORTH AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 49 EUROPE: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 50 ASIA PACIFIC: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 LATIN AMERICA: PEPTIDE SYNTHESIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.2 CHROMATOGRAPHY EQUIPMENT
6.3.2.1 Reverse-phase HPLC is used for the purification of synthetic peptides
TABLE 52 PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 54 EUROPE: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 55 ASIA PACIFIC: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 56 LATIN AMERICA: PEPTIDE SYNTHESIS CHROMATOGRAPHY EQUIPMENT MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.3.3 LYOPHILIZERS
6.3.3.1 Lyophilization enables longer shelf life and eases the transportation of peptides
TABLE 57 PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 58 NORTH AMERICA: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 59 EUROPE: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 60 ASIA PACIFIC: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 61 LATIN AMERICA: PEPTIDE SYNTHESIS LYOPHILIZERS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
6.4 SERVICES
6.4.1 RISING RESEARCH ACTIVITIES IN THE PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS FIELDS TO DRIVE MARKET GROWTH
TABLE 62 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 65 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 66 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY (Page No. - 101)
7.1 INTRODUCTION
TABLE 67 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
7.2 SOLID-PHASE PEPTIDE SYNTHESIS (SPPS)
7.2.1 EASE OF USE IS A KEY ADVANTAGE ASSOCIATED WITH SPPS TECHNOLOGY
TABLE 68 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 70 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 71 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 72 LATIN AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS
7.3.1 LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES CAN BE PRODUCED COST EFFECTIVELY WITH THE SOLUTION-PHASE PEPTIDE SYNTHESIS TECHNOLOGY
TABLE 73 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 75 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 77 LATIN AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
7.4 HYBRID & RECOMBINANT TECHNOLOGY
7.4.1 HYBRID & RECOMBINANT METHOD ENABLES THE PRODUCTION OF PEPTIDES WITH HIGHER COMPLEXITY
TABLE 78 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 79 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 80 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 81 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 82 LATIN AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
8 PEPTIDE SYNTHESIS MARKET, BY END USER (Page No. - 110)
8.1 INTRODUCTION
TABLE 83 PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 PEPTIDE SYNTHESIS PRODUCTS ARE MOST WIDELY USED BY PHARMA & BIOTEC COMPANIES FOR DRUG DEVELOPMENT APPLICATIONS
TABLE 84 GLOBAL MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2026 (USD MILLION)
TABLE 85 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 86 EUROPE: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 87 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 88 LATIN AMERICA: MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2019–2026 (USD MILLION)
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS & CROS)
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES IS DRIVING THE GROWTH OF CDMOS & CROS
TABLE 89 PEPTIDE SYNTHESIS MARKET FOR CDMOS & CROS, BY REGION, 2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: MARKET FOR CDMOS & CROS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 91 EUROPE: MARKET FOR CDMOS & CROS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 92 ASIA PACIFIC: MARKET FOR CDMOS & CROS, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 93 LATIN AMERICA:MARKET FOR CDMOS & CROS, BY COUNTRY, 2019–2026 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO DRIVE MARKET GROWTH
TABLE 94 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION)
TABLE 95 NORTH AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 96 EUROPE: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 97 ASIA PACIFIC: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 98 LATIN AMERICA: MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019–2026 (USD MILLION)
9 PEPTIDE SYNTHESIS MARKET, BY REGION (Page No. - 119)
9.1 INTRODUCTION
FIGURE 24 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 99 GLOBAL MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 25 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 100 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 101 NORTH AMERICA: MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 NORTH AMERICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 105 NORTH AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American peptide synthesis market
TABLE 106 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 107 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 108 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 US: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 110 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Availability of research funding in Canada to drive market growth
TABLE 111 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 112 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 114 CANADA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 115 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 116 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 117 EUROPE: MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 118 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 EUROPE: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 121 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Strong academic base and rising awareness are key growth drivers in Germany
TABLE 122 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 123 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 GERMANY: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 126 GERMANY: MARKET, BY END USER, 2019–2026 USD MILLION)
9.3.2 UK
9.3.2.1 Growth in life science research to drive market growth
TABLE 127 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 128 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 129 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 UK: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 131 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government funding for proteomics and genomics research to propel market growth
TABLE 132 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 133 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 135 FRANCE: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 136 FRANCE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing life science research to boost the market growth in Italy
TABLE 137 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 138 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 ITALY: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 141 ITALY: MARKET, BY END USER, 2019–2026 USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising focus on research and innovation to support market growth
TABLE 142 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 143 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 146 SPAIN: MARKET, BY END USER, 2019–2026 USD MILLION)
9.3.6 REST OF EUROPE
TABLE 147 ROE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 148 ROE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 149 ROE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 ROE: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 151 ROE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC (APAC)
FIGURE 26 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 152 ASIA PACIFIC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 153 ASIA PACIFIC: MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 154 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 156 ASIA PACIFIC: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 157 ASIA PACIFIC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to register the highest growth rate due to increasing investments in R&D
TABLE 158 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 159 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 160 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 CHINA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 162 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rising collaborations between companies in Japan to propel market growth
TABLE 163 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 164 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 165 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 166 JAPAN: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 167 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government support for scientific research to drive market growth
TABLE 168 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 169 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 171 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 172 INDIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Growing research efforts in the biopharmaceutical sector to boost market growth
TABLE 173 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 174 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 175 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 SOUTH KOREA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 177 SOUTH KOREA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.5 REST OF ASIA PACIFIC (ROAPAC)
TABLE 178 ROAPAC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 179 ROAPAC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 180 ROAPAC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 181 ROAPAC: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 182 ROAPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 183 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 184 LATIN AMERICA: MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 185 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 186 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 187 LATIN AMERICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 188 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Rising government investments in research to support market growth
TABLE 189 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 190 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 192 BRAZIL: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 193 BRAZIL: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Mexico is the second-largest pharmaceutical market in Latin America
TABLE 194 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 195 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 196 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 MEXICO: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 198 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5.3 REST OF LATIN AMERICA (ROLATAM)
TABLE 199 ROLATAM: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 200 ROLATAM: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 201 ROLATAM: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 202 ROLATAM: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 203 ROLATAM: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES AND INCREASING R&D ACTIVITIES TO DRIVE MARKET GROWTH
TABLE 204 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 205 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 206 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 171)
10.1 OVERVIEW
10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
FIGURE 27 KEY PLAYER STRATEGIES IN THE PEPTIDE SYNTHESIS MARKET, 2018-2021
10.3 MARKET SHARE ANALYSIS
FIGURE 28 PEPTIDE SYNTHESIS MARKET: MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 209 GLOBAL MARKET: DEGREE OF COMPETITION
10.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE GLOBAL MARKET, 2018 TO 2020
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 30 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 31 GLOBAL MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 210 PRODUCT/SERVICE PORTFOLIO ANALYSIS: GLOBAL MARKET (2020)
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 211 GEOGRAPHIC REVENUE MIX: PEPTIDE SYNTHESIS MARKET (2020)
10.9 COMPETITIVE SCENARIO
TABLE 212 PRODUCT & SERVICE LAUNCHES
TABLE 213 DEALS
TABLE 214 OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 185)
11.1 KEY PLAYERS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 GENSCRIPT BIOTECH CORPORATION
TABLE 215 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
FIGURE 32 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2020)
11.1.2 THERMO FISHER SCIENTIFIC
TABLE 216 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 33 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
11.1.3 MERCK KGAA
TABLE 217 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.4 BACHEM HOLDING AG
TABLE 218 BACHEM HOLDING AG: BUSINESS OVERVIEW
FIGURE 35 BACHEM HOLDING AG: COMPANY SNAPSHOT (2020)
11.1.5 KANEKA CORPORATION
TABLE 219 KANEKA CORPORATION: BUSINESS OVERVIEW
FIGURE 36 KANEKA CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 BIOTAGE AB
TABLE 220 BIOTAGE AB: BUSINESS OVERVIEW
FIGURE 37 BIOTAGE AB: COMPANY SNAPSHOT (2020)
11.1.7 SYNGENE INTERNATIONAL LIMITED
TABLE 221 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW
FIGURE 38 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020)
11.1.8 MESA LABORATORIES, INC.
TABLE 222 MESA LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 39 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.9 CEM CORPORATION
TABLE 223 CEM CORPORATION: BUSINESS OVERVIEW
11.1.10 PROTEOGENIX
TABLE 224 PROTEOGENIX: BUSINESS OVERVIEW
11.1.11 BIO-SYNTHESIS INC.
TABLE 225 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW
11.1.12 DALTON PHARMA SERVICES
TABLE 226 DALTON PHARMA SERVICES: BUSINESS OVERVIEW
11.1.13 AAPPTEC
TABLE 227 AAPPTEC: BUSINESS OVERVIEW
11.1.14 VIVITIDE
TABLE 228 VIVITIDE: BUSINESS OVERVIEW
11.1.15 ANYGEN CO., LTD.
TABLE 229 ANYGEN CO., LTD.: BUSINESS OVERVIEW
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 CSBIO
11.2.2 ADVANCED CHEMTECH
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD.
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH
11.2.5 AMBIOPHARM INC.
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD.
11.2.7 CORDENPHARMA INTERNATIONAL
11.2.8 CHEMPEP INC.
11.2.9 CPC SCIENTIFIC INC.
11.2.10 PUROLITE PVT.LTD.
12 APPENDIX (Page No. - 231)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global peptide synthesis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from government sources, such as Association of Biomolecular Resource Facilities, Journal of the American Chemical Society, American Peptide Society, Australian Peptide Association, European Peptide Society, Indian Peptide Society, Protein Science Society of Japan (PSSJ), American Peptide Society (APS), National Institutes of Health (NIH), and World Health Organization (WHO). Secondary sources also include corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global peptide synthesis market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global peptide synthesis market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CDMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including North America, Europe, the Asia Pacific, and the Rest of the World. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the peptide synthesis market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the peptide synthesis market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive primary and secondary research.
- The revenues generated from the peptide synthesis business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Report Objectives
- To define, describe, and forecast the peptide synthesis market by product & service, technology, end user, and region
- To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to the individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments in North America, Europe, Asia Pacific,
- Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their market shares and core competencies2 in the global peptide synthesis market
- To track and analyze competitive developments such as product & service launches, partnerships, collaborations, agreements, expansions, and acquisitions in the global peptide synthesis market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Growth opportunities and latent adjacency in Peptide Synthesis Market